Imatinib treatment of ankylosing spondylitis in a patient resistant to NSAIDs and infliximab.
Nazarinia
Mohammad Ali
MA
Department of Rheumatology, Shiraz University of Medical Sciences, Shiraz, Iran.
Ghaffarpasand
Fariborz
F
Seraj
Seyed Reza
SR
Heiran
Hamid Reza
HR
Khojasteh
Habib Nourani
HN
D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D001549:Benzamides; D004351:Drug Resistance; D006801:Humans; D000068877:Imatinib Mesylate; D000069285:Infliximab; D008297:Male; D010879:Piperazines / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*; D011859:Radiography; D013167:Spondylitis, Ankylosing / Q000000981:diagnostic imaging / Q000188:drug therapy*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000911:Antibodies, Monoclonal; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate; D000069285:Infliximab